nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—Hot flush—Epirubicin—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Nitroglycerin—Confusional state—Irinotecan—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Nitroglycerin—Asthenia—Erlotinib—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Epirubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Nitroglycerin—Pruritus—Tamoxifen—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Nitroglycerin—Infection—Irinotecan—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Nitroglycerin—Pruritus—Erlotinib—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Nitroglycerin—Shock—Irinotecan—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Nitroglycerin—Nervous system disorder—Irinotecan—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Nitroglycerin—Eczema—Doxorubicin—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Nitroglycerin—Rhinitis—Docetaxel—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Nitroglycerin—Infection—Gemcitabine—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Nitroglycerin—Confusional state—Fluorouracil—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Nitroglycerin—Pharyngitis—Docetaxel—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Nitroglycerin—Abdominal pain—Sunitinib—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Nitroglycerin—Body temperature increased—Sunitinib—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Nitroglycerin—Oedema peripheral—Docetaxel—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Nitroglycerin—Nervous system disorder—Gemcitabine—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Nitroglycerin—Infection—Fluorouracil—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Nitroglycerin—Renal failure acute—Doxorubicin—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Nitroglycerin—Skin disorder—Gemcitabine—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Nitroglycerin—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Nitroglycerin—Hot flush—Doxorubicin—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Nitroglycerin—Visual impairment—Docetaxel—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Nitroglycerin—Dizziness—Tamoxifen—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Nitroglycerin—Tachycardia—Fluorouracil—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Nitroglycerin—Hypotension—Irinotecan—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Nitroglycerin—Dizziness—Erlotinib—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Nitroglycerin—Hypotension—Gemcitabine—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Nitroglycerin—Flushing—Docetaxel—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Nitroglycerin—Cardiac disorder—Docetaxel—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Nitroglycerin—Vomiting—Tamoxifen—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Nitroglycerin—Paraesthesia—Irinotecan—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Nitroglycerin—Hypotension—Fluorouracil—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Nitroglycerin—Hypersensitivity—Sunitinib—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Nitroglycerin—Rash—Tamoxifen—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Nitroglycerin—Dermatitis—Tamoxifen—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Nitroglycerin—Vomiting—Erlotinib—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Nitroglycerin—Dyspnoea—Irinotecan—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Nitroglycerin—Somnolence—Irinotecan—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Nitroglycerin—Headache—Tamoxifen—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Nitroglycerin—Rash—Erlotinib—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Nitroglycerin—Dermatitis—Erlotinib—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Nitroglycerin—Angiopathy—Docetaxel—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Nitroglycerin—Immune system disorder—Docetaxel—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Nitroglycerin—Headache—Erlotinib—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Nitroglycerin—Paraesthesia—Gemcitabine—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Nitroglycerin—Asthenia—Sunitinib—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Nitroglycerin—Arrhythmia—Docetaxel—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Nitroglycerin—Dyspnoea—Gemcitabine—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Nitroglycerin—Somnolence—Gemcitabine—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Nitroglycerin—Paraesthesia—Fluorouracil—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Nitroglycerin—Pruritus—Sunitinib—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Nitroglycerin—Dyspnoea—Fluorouracil—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Nitroglycerin—Mental disorder—Docetaxel—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Nitroglycerin—Somnolence—Fluorouracil—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Nitroglycerin—Erythema—Docetaxel—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Nitroglycerin—Nausea—Tamoxifen—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Nitroglycerin—Nausea—Erlotinib—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Nitroglycerin—Feeling abnormal—Irinotecan—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Nitroglycerin—Dizziness—Sunitinib—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Nitroglycerin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Nitroglycerin—Angina pectoris—Epirubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Nitroglycerin—Body temperature increased—Irinotecan—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Nitroglycerin—Abdominal pain—Irinotecan—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Nitroglycerin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Nitroglycerin—Vomiting—Sunitinib—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Nitroglycerin—Body temperature increased—Gemcitabine—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Nitroglycerin—Rash—Sunitinib—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Nitroglycerin—Dermatitis—Sunitinib—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Nitroglycerin—Urticaria—Fluorouracil—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Nitroglycerin—Headache—Sunitinib—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Nitroglycerin—Syncope—Docetaxel—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Nitroglycerin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Nitroglycerin—Palpitations—Docetaxel—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Nitroglycerin—Loss of consciousness—Docetaxel—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Nitroglycerin—Angina pectoris—Doxorubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Nitroglycerin—Hypersensitivity—Irinotecan—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Nitroglycerin—Infestation NOS—Epirubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Nitroglycerin—Drowsiness—Epirubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Nitroglycerin—Infestation—Epirubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Nitroglycerin—Nausea—Sunitinib—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Nitroglycerin—Asthenia—Irinotecan—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Nitroglycerin—Stomatitis—Epirubicin—pancreatic cancer	0.00134	0.00134	CcSEcCtD
Nitroglycerin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Nitroglycerin—Sweating—Epirubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Nitroglycerin—Asthenia—Gemcitabine—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Nitroglycerin—Confusional state—Docetaxel—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Nitroglycerin—Pruritus—Gemcitabine—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Nitroglycerin—Infection—Docetaxel—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Nitroglycerin—Shock—Docetaxel—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Nitroglycerin—Nervous system disorder—Docetaxel—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Nitroglycerin—Pruritus—Fluorouracil—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Nitroglycerin—Infestation NOS—Doxorubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Nitroglycerin—Drowsiness—Doxorubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Nitroglycerin—Infestation—Doxorubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Nitroglycerin—Tachycardia—Docetaxel—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Nitroglycerin—Skin disorder—Docetaxel—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Nitroglycerin—Bradycardia—Epirubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Nitroglycerin—Dizziness—Irinotecan—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Nitroglycerin—Stomatitis—Doxorubicin—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Nitroglycerin—Rhinitis—Epirubicin—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Nitroglycerin—Pharyngitis—Epirubicin—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Nitroglycerin—Sweating—Doxorubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Nitroglycerin—Oedema peripheral—Epirubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Nitroglycerin—Hypotension—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Nitroglycerin—Vomiting—Irinotecan—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Nitroglycerin—Dizziness—Fluorouracil—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Nitroglycerin—Visual impairment—Epirubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Nitroglycerin—Rash—Irinotecan—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Nitroglycerin—Dermatitis—Irinotecan—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Nitroglycerin—Headache—Irinotecan—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Nitroglycerin—Paraesthesia—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Nitroglycerin—Vomiting—Gemcitabine—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Nitroglycerin—Bradycardia—Doxorubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Nitroglycerin—Dyspnoea—Docetaxel—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Nitroglycerin—Somnolence—Docetaxel—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Nitroglycerin—Rash—Gemcitabine—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Nitroglycerin—Dermatitis—Gemcitabine—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Nitroglycerin—Headache—Gemcitabine—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Nitroglycerin—Flushing—Epirubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Nitroglycerin—Cardiac disorder—Epirubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Nitroglycerin—Vomiting—Fluorouracil—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Nitroglycerin—Rhinitis—Doxorubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Nitroglycerin—Rash—Fluorouracil—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Nitroglycerin—Dermatitis—Fluorouracil—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Nitroglycerin—Pharyngitis—Doxorubicin—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Nitroglycerin—Headache—Fluorouracil—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Nitroglycerin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00113	0.00113	CcSEcCtD
Nitroglycerin—Angiopathy—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Nitroglycerin—Nausea—Irinotecan—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Nitroglycerin—Immune system disorder—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Nitroglycerin—Arrhythmia—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Nitroglycerin—Visual impairment—Doxorubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Nitroglycerin—Nausea—Gemcitabine—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Nitroglycerin—Mental disorder—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Nitroglycerin—Erythema—Epirubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Nitroglycerin—Feeling abnormal—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Nitroglycerin—Nausea—Fluorouracil—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Nitroglycerin—Flushing—Doxorubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Nitroglycerin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Nitroglycerin—Angiopathy—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Nitroglycerin—Immune system disorder—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Nitroglycerin—Body temperature increased—Docetaxel—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Nitroglycerin—Abdominal pain—Docetaxel—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Nitroglycerin—Arrhythmia—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Nitroglycerin—Vision blurred—Epirubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Nitroglycerin—Mental disorder—Doxorubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Nitroglycerin—Erythema—Doxorubicin—pancreatic cancer	0.000997	0.000997	CcSEcCtD
Nitroglycerin—Agitation—Epirubicin—pancreatic cancer	0.00099	0.00099	CcSEcCtD
Nitroglycerin—Vertigo—Epirubicin—pancreatic cancer	0.000968	0.000968	CcSEcCtD
Nitroglycerin—Syncope—Epirubicin—pancreatic cancer	0.000966	0.000966	CcSEcCtD
Nitroglycerin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000961	0.000961	CcSEcCtD
Nitroglycerin—Palpitations—Epirubicin—pancreatic cancer	0.000952	0.000952	CcSEcCtD
Nitroglycerin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000947	0.000947	CcSEcCtD
Nitroglycerin—Vision blurred—Doxorubicin—pancreatic cancer	0.00094	0.00094	CcSEcCtD
Nitroglycerin—Asthenia—Docetaxel—pancreatic cancer	0.000935	0.000935	CcSEcCtD
Nitroglycerin—Pruritus—Docetaxel—pancreatic cancer	0.000922	0.000922	CcSEcCtD
Nitroglycerin—Agitation—Doxorubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000911	0.000911	CcSEcCtD
Nitroglycerin—Vertigo—Doxorubicin—pancreatic cancer	0.000896	0.000896	CcSEcCtD
Nitroglycerin—Syncope—Doxorubicin—pancreatic cancer	0.000894	0.000894	CcSEcCtD
Nitroglycerin—Confusional state—Epirubicin—pancreatic cancer	0.000887	0.000887	CcSEcCtD
Nitroglycerin—Palpitations—Doxorubicin—pancreatic cancer	0.000881	0.000881	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000879	0.000879	CcSEcCtD
Nitroglycerin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Nitroglycerin—Infection—Epirubicin—pancreatic cancer	0.000874	0.000874	CcSEcCtD
Nitroglycerin—Shock—Epirubicin—pancreatic cancer	0.000865	0.000865	CcSEcCtD
Nitroglycerin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000862	0.000862	CcSEcCtD
Nitroglycerin—Dizziness—Docetaxel—pancreatic cancer	0.000862	0.000862	CcSEcCtD
Nitroglycerin—Tachycardia—Epirubicin—pancreatic cancer	0.000858	0.000858	CcSEcCtD
Nitroglycerin—Skin disorder—Epirubicin—pancreatic cancer	0.000854	0.000854	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00085	0.00085	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000843	0.000843	CcSEcCtD
Nitroglycerin—Vomiting—Docetaxel—pancreatic cancer	0.000829	0.000829	CcSEcCtD
Nitroglycerin—Rash—Docetaxel—pancreatic cancer	0.000822	0.000822	CcSEcCtD
Nitroglycerin—Hypotension—Epirubicin—pancreatic cancer	0.000822	0.000822	CcSEcCtD
Nitroglycerin—Dermatitis—Docetaxel—pancreatic cancer	0.000821	0.000821	CcSEcCtD
Nitroglycerin—Confusional state—Doxorubicin—pancreatic cancer	0.00082	0.00082	CcSEcCtD
Nitroglycerin—Headache—Docetaxel—pancreatic cancer	0.000817	0.000817	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000814	0.000814	CcSEcCtD
Nitroglycerin—Infection—Doxorubicin—pancreatic cancer	0.000808	0.000808	CcSEcCtD
Nitroglycerin—Shock—Doxorubicin—pancreatic cancer	0.0008	0.0008	CcSEcCtD
Nitroglycerin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000798	0.000798	CcSEcCtD
Nitroglycerin—Tachycardia—Doxorubicin—pancreatic cancer	0.000794	0.000794	CcSEcCtD
Nitroglycerin—Skin disorder—Doxorubicin—pancreatic cancer	0.00079	0.00079	CcSEcCtD
Nitroglycerin—Paraesthesia—Epirubicin—pancreatic cancer	0.00079	0.00079	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Nitroglycerin—Dyspnoea—Epirubicin—pancreatic cancer	0.000784	0.000784	CcSEcCtD
Nitroglycerin—Somnolence—Epirubicin—pancreatic cancer	0.000782	0.000782	CcSEcCtD
Nitroglycerin—Nausea—Docetaxel—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Nitroglycerin—Hypotension—Doxorubicin—pancreatic cancer	0.00076	0.00076	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000759	0.000759	CcSEcCtD
Nitroglycerin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000731	0.000731	CcSEcCtD
Nitroglycerin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000725	0.000725	CcSEcCtD
Nitroglycerin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000725	0.000725	CcSEcCtD
Nitroglycerin—Somnolence—Doxorubicin—pancreatic cancer	0.000723	0.000723	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000719	0.000719	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000702	0.000702	CcSEcCtD
Nitroglycerin—Urticaria—Epirubicin—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Nitroglycerin—Abdominal pain—Epirubicin—pancreatic cancer	0.000695	0.000695	CcSEcCtD
Nitroglycerin—Body temperature increased—Epirubicin—pancreatic cancer	0.000695	0.000695	CcSEcCtD
Nitroglycerin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000665	0.000665	CcSEcCtD
Nitroglycerin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000648	0.000648	CcSEcCtD
Nitroglycerin—Urticaria—Doxorubicin—pancreatic cancer	0.000646	0.000646	CcSEcCtD
Nitroglycerin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Nitroglycerin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Nitroglycerin—Asthenia—Epirubicin—pancreatic cancer	0.000631	0.000631	CcSEcCtD
Nitroglycerin—Pruritus—Epirubicin—pancreatic cancer	0.000622	0.000622	CcSEcCtD
Nitroglycerin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000599	0.000599	CcSEcCtD
Nitroglycerin—Asthenia—Doxorubicin—pancreatic cancer	0.000584	0.000584	CcSEcCtD
Nitroglycerin—Dizziness—Epirubicin—pancreatic cancer	0.000581	0.000581	CcSEcCtD
Nitroglycerin—Pruritus—Doxorubicin—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Nitroglycerin—Vomiting—Epirubicin—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Nitroglycerin—Rash—Epirubicin—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Nitroglycerin—Dermatitis—Epirubicin—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Nitroglycerin—Headache—Epirubicin—pancreatic cancer	0.000551	0.000551	CcSEcCtD
Nitroglycerin—Dizziness—Doxorubicin—pancreatic cancer	0.000538	0.000538	CcSEcCtD
Nitroglycerin—Nausea—Epirubicin—pancreatic cancer	0.000522	0.000522	CcSEcCtD
Nitroglycerin—Vomiting—Doxorubicin—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Nitroglycerin—Rash—Doxorubicin—pancreatic cancer	0.000513	0.000513	CcSEcCtD
Nitroglycerin—Dermatitis—Doxorubicin—pancreatic cancer	0.000513	0.000513	CcSEcCtD
Nitroglycerin—Headache—Doxorubicin—pancreatic cancer	0.00051	0.00051	CcSEcCtD
Nitroglycerin—Nausea—Doxorubicin—pancreatic cancer	0.000483	0.000483	CcSEcCtD
